Bromo- and extraterminal domain protein inhibition improves immunotherapy efficacy in hepatocellular carcinoma.
Liu C, Miao X, Wang Y, Wen L, Cheng X, Kong D, Zhao P, Song D, Wang X, Ding X, Xia H, Wang W, Sun Q, Gong W.
Liu C, et al. Among authors: kong d.
Cancer Sci. 2020 Oct;111(10):3503-3515. doi: 10.1111/cas.14588. Epub 2020 Aug 17.
Cancer Sci. 2020.
PMID: 32726482
Free PMC article.